Prof. Dr. Hans-Martin Jäck

Picture of Hans-Martin Jäck


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

SARS-CoV-2 BA.2.86 enters lung cells and evades neutralizing antibodies with high efficiency (2024) Zhang L, Kempf A, Nehlmeier I, Cossmann A, Richter A, Bdeir N, Graichen L, et al. Journal article Broadly neutralizing SARS-CoV-2 antibodies through epitope-based selection from convalescent patients (2023) Rouet R, Henry JY, Johansen MD, Sobti M, Balachandran H, Langley DB, Walker GJ, et al. Journal article Neutralisation sensitivity of SARS-CoV-2 lineages EG.5.1 and XBB.2.3 (2023) Zhang L, Kempf A, Nehlmeier I, Cossmann A, Dopfer-Jablonka A, Stankov MV, Schulz S, et al. Journal article Neutralisation sensitivity of the SARS-CoV-2 XBB.1 lineage (2023) Arora P, Cossmann A, Schulz S, Ramos GM, Stankov MV, Jäck HM, Behrens GM, et al. Journal article Host cell entry and neutralisation sensitivity of the SARS-CoV-2 XBB.1.16 lineage (2023) Nehlmeier I, Kempf A, Arora P, Cossmann A, Dopfer-Jablonka A, Stankov MV, Schulz S, et al. Journal article The intestine: A highly dynamic microenvironment for IgA plasma cells (2023) Pracht K, Wittner J, Kagerer F, Jäck HM, Schuh W Journal article, Review article Profound neutralization evasion and augmented host cell entry are hallmarks of the fast-spreading SARS-CoV-2 lineage XBB.1.5 (2023) Hoffmann M, Arora P, Nehlmeier I, Kempf A, Cossmann A, Schulz S, Morillas Ramos G, et al. Journal article Omicron sublineage BQ.1.1 resistance to monoclonal antibodies (2023) Arora P, Kempf A, Nehlmeier I, Schulz S, Jäck HM, Pöhlmann S, Hoffmann M Journal article The microRNA processing subunit DGCR8 is required for a T cell-dependent germinal center response (2022) Daum P, Ottmann S, Meinzinger J, Schulz S, Corte-Real J, Hauke M, Roth E, et al. Journal article The effect of cilgavimab and neutralisation by vaccine-induced antibodies in emerging SARS-CoV-2 BA.4 and BA.5 sublineages (2022) Arora P, Zhang L, Nehlmeier I, Kempf A, Cossmann A, Dopfer-Jablonka A, Schulz SR, et al. Journal article